ENGAGing men in HIV prevention and care
CTN 300: The Engage Study is investigating the use of PrEP among urban Canadian gay, bisexual, and other men who have sex with men
Learn MoreJune 16, 2021
Does the COVID-19 vaccine work for people living with HIV?
A new national study, called HIVCOV (CTN 328), will assess COVID-19 vaccine immune responses and effectiveness among people living with HIV
Learn More
Understanding the impacts of prenatal antiretroviral medications on children
A new CTN study investigates how exposure to HIV and antiretroviral drugs during pregnancy could have long-term effects for the millions of kids who were born to mothers living with HIV, but who did not acquire the virus themselves
Learn More
TEACHHing service providers how to best care for trans people
March 31 marks the International Transgender Day of Visibility, an annual event dedicated to celebrating...
Learn More
Seven ways the Community Advisory Committee strengthens HIV research
Here are the seven ways that the CTN works towards the meaningful involvement of people...
Learn More
Treating liver disease in people living with HIV
The CTNPT 024 team investigated whether vitamin E could be a treatment option for NASH, a type of liver disease that is more common among people living with HIV
Learn More
New research comparing HIV medications set to change international recommendations
The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
Learn More
Examining the results of CTN 297: Black PRAISE
The Black PRAISE team have pioneered a novel intervention aimed at reducing HIV-related stigma while strengthening the HIV knowledge base among Black church congregations in Ontario
Learn More
Engage-COVID-19
New funding for CTN 300-2 will allow the study team to document COVID-19 infection, immunity, and related determinants in gay, bisexual, and other men who have sex with men
Learn More